BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16639867)

  • 1. Modified dexamethasone suppression-corticotropin-releasing hormone stimulation test: A pilot study of young healthy volunteers and implications for alcoholism research in adolescents and young adults.
    Sher L; Cooper TB; Mann JJ; Oquendo MA
    Int J Adolesc Med Health; 2006; 18(1):133-7. PubMed ID: 16639867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.
    Sher L
    ScientificWorldJournal; 2006 Oct; 6():1398-404. PubMed ID: 17086345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L; Oquendo MA; Burke AK; Cooper TB; Mann JJ
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal.
    Hundt W; Zimmermann U; Pöttig M; Spring K; Holsboer F
    Alcohol Clin Exp Res; 2001 May; 25(5):687-91. PubMed ID: 11371718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics.
    Costa A; Bono G; Martignoni E; Merlo P; Sances G; Nappi G
    Psychoneuroendocrinology; 1996 Apr; 21(3):263-75. PubMed ID: 8817725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher overcommitment to work is associated with higher plasma cortisol but not ACTH responses in the combined dexamethasone/CRH test in apparently healthy men and women.
    Wirtz PH; Siegrist J; Schuhmacher A; Hoefels S; Maier W; Zobel AW
    Psychoneuroendocrinology; 2010 May; 35(4):536-43. PubMed ID: 19818562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder.
    Petrowski K; Wintermann GB; Kirschbaum C; Bornstein SR
    Psychoneuroendocrinology; 2012 Aug; 37(8):1199-208. PubMed ID: 22277728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothalamic-pituitary-adrenal system regulation in recently detoxified alcoholics is not altered by one week of treatment with acamprosate.
    Zimmerman U; Spring K; Koller G; Holsboer F; Soyka M
    Pharmacopsychiatry; 2004 May; 37(3):98-102. PubMed ID: 15179967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.
    Schüle C; Baghai T; Zwanzger P; Minov C; Padberg F; Rupprecht R
    J Psychiatr Res; 2001; 35(4):239-47. PubMed ID: 11578642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
    Gonul AS; Cetinkalp S; Tunay S; Polat I; Simsek F; Aksoy B; Kizilates G; Erdogan Y; Coburn KL
    J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.
    Lammers CH; Garcia-Borreguero D; Schmider J; Gotthardt U; Dettling M; Holsboer F; Heuser IJ
    Biol Psychiatry; 1995 Dec; 38(12):803-7. PubMed ID: 8750038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptides and the hypothalamic-pituitary-adrenocortical (HPA) system: review of recent research strategies in depression.
    Hatzinger M
    World J Biol Psychiatry; 2000 Apr; 1(2):105-11. PubMed ID: 12607206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between psychological distress, coping styles, and HPA axis reactivity in healthy adults.
    Hori H; Ozeki Y; Teraishi T; Matsuo J; Kawamoto Y; Kinoshita Y; Suto S; Terada S; Higuchi T; Kunugi H
    J Psychiatr Res; 2010 Oct; 44(14):865-73. PubMed ID: 20334880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In healthy young and elderly adults, hypothalamic-pituitary-adrenocortical axis reactivity (HPA AR) varies with increasing pharmacological challenge and with age, but not with gender.
    Hatzinger M; Brand S; Herzig N; Holsboer-Trachsler E
    J Psychiatr Res; 2011 Oct; 45(10):1373-80. PubMed ID: 21641616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to measure glucocorticoid receptor's sensitivity in patients with stress-related psychiatric disorders.
    Leistner C; Menke A
    Psychoneuroendocrinology; 2018 May; 91():235-260. PubMed ID: 29449045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
    Nikisch G; Mathé AA; Czernik A; Thiele J; Bohner J; Eap CB; Agren H; Baumann P
    Psychopharmacology (Berl); 2005 Oct; 181(4):751-60. PubMed ID: 15988572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
    Huang TS
    J Endocrinol Invest; 1997; 20(7):393-6. PubMed ID: 9309537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined dexamethasone/CRH test in rats: hypothalamo-pituitary-adrenocortical system alterations in aging.
    Hatzinger M; Reul JM; Landgraf R; Holsboer F; Neumann I
    Neuroendocrinology; 1996 Nov; 64(5):349-56. PubMed ID: 8930935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
    Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I
    Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.